Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,41 EUR | +22,02 % | -89,27 % | -85,86 % |
Resumen de negocios
El grupo tiene un producto en fase II/III de desarrollo clínico (Glenzocimab).
Número de empleados: 29
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gilles Avenard
FOU | Founder | - | 26/11/13 |
Eric Cohen
DFI | Director of Finance/CFO | - | - |
Adeline Meilhoc
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01/11/18 | |
Aymeric Humblot
ADM | Chief Administrative Officer | - | - |
Sophie Binay
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yannick Plétan
CTO | Chief Tech/Sci/R&D Officer | - | 20/12/17 |
James Stearns
PRN | Corporate Officer/Principal | - | - |
Jessica Jami
LAW | General Counsel | - | 01/11/19 |
Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gilles Avenard
FOU | Founder | - | 26/11/13 |
Catherine Boule
BRD | Director/Board Member | - | - |
Alain Munoz
CHM | Chairman | 75 | 15/06/21 |
Alain Parthoens
BRD | Director/Board Member | 64 | 24/10/18 |
Rinaldo del Bono
BRD | Director/Board Member | - | - |
Guy Heynen
BRD | Director/Board Member | - | - |
Patricia Zilliox
BRD | Director/Board Member | - | 26/01/23 |
Corporate Officer/Principal | - | - | |
Leila Nicolas
BRD | Director/Board Member | - | - |
Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 12 338 781 | 12 338 781 ( 100,00 %) | 0 | 100,00 % |
Información de la empresa
Acticor Biotech SAS
Bâtiment Inserm U1148 Hôpital Bichat
75877, Paris
+33 6 76 23 38 13
http://www.acticor-biotech.comSector
Revisiones del BPA
Beneficios anuales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-85,86 % | 5,77 M | |
-3,46 % | 102 mil M | |
+1,41 % | 96,29 mil M | |
+2,13 % | 22,18 mil M | |
-15,84 % | 21,2 mil M | |
-9,21 % | 18,31 mil M | |
-39,98 % | 17,38 mil M | |
-14,65 % | 16,36 mil M | |
+4,39 % | 13,97 mil M | |
+31,35 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción ALACT
- Empresa Acticor Biotech SAS